Evidence map›Paper›PMID 37759937›Full record

ReviewBrain sciences2023

Inflammatory Mechanisms in a Neurovascular Disease: Cerebral Cavernous Malformation.

Ying Li, Abhinav Srinath, Roberto J Alcazar-Felix, Stephanie Hage, Akash Bindal, Rhonda Lightle, Robert Shenkar, Changbin Shi, Romuald Girard, Issam A Awad

Open access · goldAbstract readReview
In one paragraph

Review in Brain sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 3 syntheses or guidelines pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. SilencingInternational journal of molecular sciences · 2025
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Ying LiDepartment of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.ORCID 0000-0002-4107-5442
Abhinav SrinathNeurovascular Surgery Program, Department of Neurological Surgery, The University of Chicago, Chicago, IL 60637, USA.
Roberto J Alcazar-FelixNeurovascular Surgery Program, Department of Neurological Surgery, The University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0003-1214-5576
Stephanie HageNeurovascular Surgery Program, Department of Neurological Surgery, The University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0002-8168-4621
Akash BindalNeurovascular Surgery Program, Department of Neurological Surgery, The University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0002-9834-6979
Rhonda LightleNeurovascular Surgery Program, Department of Neurological Surgery, The University of Chicago, Chicago, IL 60637, USA.
Robert ShenkarNeurovascular Surgery Program, Department of Neurological Surgery, The University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0002-1300-6845
Changbin ShiDepartment of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Romuald GirardNeurovascular Surgery Program, Department of Neurological Surgery, The University of Chicago, Chicago, IL 60637, USA.
Issam A AwadNeurovascular Surgery Program, Department of Neurological Surgery, The University of Chicago, Chicago, IL 60637, USA.
University of Chicago · USHarbin Medical University · CN

Funding

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)T32HD007009 · NICHD · UNIVERSITY OF CHICAGO · PI NANCY B SCHWARTZ · 1985 to 2026
$13.0M
Somatic mutation(s) and cellular changes in CCM pathogenesisP01NS092521 · NINDS · DUKE UNIVERSITY · PI MARCHUK, DOUGLAS A. · 2015 to 2024
$12.9M
Biomarkers of Cerebral Cavernous Angioma with Symptomatic Hemorrhage (CASH) - SupplementalR01NS114552 · NINDS · UNIVERSITY OF CHICAGO · PI AWAD, ISSAM A · 2020 to 2024
$3.4M
NICHD NIH HHS T32 HD007009NINDS NIH HHS P01 NS092521NINDS NIH HHS R01 NS114552
6 · The paper itself

Abstract

Cerebral cavernous malformation (CCM) is a common cerebrovascular malformation causing intracranial hemorrhage, seizures, and focal neurologic deficits. A unique CCM lesional inflammatory microenvironment has been shown to influence the clinical course of the disease. This review addresses the inflammatory cell infiltrate in the CCM lesion and the role of a defined antigen-driven immune response in pathogenicity. We summarize immune mechanisms associated with the loss of the CCM gene and disease progression, including the potential role of immunothrombosis. We also review evidence of circulating inflammatory biomarkers associated with CCM disease and its clinical activity. We articulate future directions for this research, including the role of individual cell type contributions to the immune response in CCM, single cell transcriptomics of inflammatory cells, biomarker development, and therapeutic implications. The concepts are applicable for developing diagnostic and treatment strategies for CCM and for studying other neurovascular diseases.

Indexed as

cerebral cavernous malformationimmune responseimmunothrombosisinflammationtranscriptome

Identifiers

PMID37759937
PMCPMC10526329
OpenAlexW4386814378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.